The inquiry targets Twin Vee PowerCats Co. (NASDAQ: VEEE) regarding its proposed merger with USFM Corporation, as well as NextCure, Inc. (NASDAQ: NXTC) and its deal with Avere Therapeutics. Under the terms of the NextCure transaction, current shareholders are slated to retain approximately 1.21% of the newly combined entity.
Simultaneously, the firm is scrutinizing the sale of TriCo Bancshares (NASDAQ: TCBK) to First Hawaiian, Inc. (NASDAQ: FHB). The proposed agreement stipulates that TriCo shareholders will hold roughly 35% of the combined company, while First Hawaiian investors are expected to control the remaining 65%. Shareholders seeking further details or wishing to discuss potential legal concerns can contact attorney Juan Monteverde at the firm’s Empire State Building offices.
Comments (0)
No comments yet. Be the first!